OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
OKUR
51 hedge funds and large institutions have $49M invested in OnKure Therapeutics, Inc. Class A Common Stock in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
-15
Holders Change %
-22.73%
% of All Funds
0.74%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
16
Reduced
14
Closed
21
Calls
$103K
Puts
–
Net Calls
+$103K
Net Calls Change
-$22K
Top Buyers
1 |
IC
Ikarian Capital
Dallas,
Texas
|
$1.74M |
2 |
BCM
BML Capital Management
Zionsville,
Indiana
|
$5.88M |
3 |
VPC
Vestal Point Capital
New York
|
$1.36M |
4 |
Two Sigma Advisers
New York
|
$385K |
5 |
HCM
Highbridge Capital Management
New York
|
$5.21M |
Top Sellers
1 |
OM
Opaleye Management
Boston,
Massachusetts
|
$0 |
2 |
Morgan Stanley
New York
|
$110K |
3 |
Goldman Sachs
New York
|
$24K |
4 |
Northern Trust
Chicago,
Illinois
|
$74.8K |
5 |
BlackRock
New York
|
$376K |